# Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms

> **NCT06955533** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 64 (actual)

## Conditions studied

- Stent Related Symptoms

## Interventions

- **DRUG:** Double dose tamsulosin and solifenacin
- **DRUG:** Single dose tamsulosin and solifenacin

## Key facts

- **NCT ID:** NCT06955533
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06955533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06955533, "Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06955533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*